Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORLUX for psychotic major depression
NCT00128479Phase 3Completed
- Sponsor
- Corcept Therapeutics
- Start
- Sep 2004
- Primary completion
- Jan 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of mifepristone, sponsored by Corcept Therapeutics. Started Sep 2004; status: completed.
02
Drugs
mifepristone
Beyond the preview
Go deeper on NCT00128479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00128479.